Literature DB >> 35110219

The Place and Importance of SBRT in Early Stage NSCLC.

Yasemin Benderli Cihan1.   

Abstract

Entities:  

Year:  2021        PMID： 35110219      PMCID： PMC8975360          DOI： 10.5152/TurkThoracJ.2021.0012

Source DB:  PubMed          Journal:  Turk Thorac J        ISSN： 2148-7197


× No keyword cloud information.
  10 in total

1.  Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group.

Authors:  R J Ginsberg; L V Rubinstein
Journal:  Ann Thorac Surg       Date:  1995-09       Impact factor: 4.330

2.  A national analysis of wedge resection versus stereotactic body radiation therapy for stage IA non-small cell lung cancer.

Authors:  Babatunde A Yerokun; Chi-Fu Jeffrey Yang; Brian C Gulack; Xuechan Li; Michael S Mulvihill; Lin Gu; Xiaofei Wang; David H Harpole; Thomas A D'Amico; Mark F Berry; Matthew G Hartwig
Journal:  J Thorac Cardiovasc Surg       Date:  2017-04-04       Impact factor: 5.209

3.  Stereotactic body radiation therapy versus sublobar resection for stage I NSCLC.

Authors:  Bradley G Ackerson; Betty C Tong; Julian C Hong; Lin Gu; Junzo Chino; Jacob W Trotter; Thomas A D'Amico; Jordan A Torok; Kyle Lafata; Catherine Chang; Chris R Kelsey
Journal:  Lung Cancer       Date:  2018-09-25       Impact factor: 5.705

4.  Clinical Outcomes After Lung Stereotactic Body Radiation Therapy in Patients With or Without a Prior Lung Resection.

Authors:  Ying Hou; Gretchen Hermann; John H Lewis; Hugo J Aerts; Elizabeth H Baldini; Aileen B Chen; Yolonda L Colson; Fred L Hacker; Joseph H Killoran; David E Kozono; Matthew Wagar; Jon O Wee; Raymond H Mak
Journal:  Am J Clin Oncol       Date:  2018-07       Impact factor: 2.339

5.  Sublobar resection with brachytherapy versus lobectomy for stage Ib nonsmall cell lung cancer.

Authors:  Thomas J Birdas; Richard P M Koehler; Athanasios Colonias; Mark Trombetta; Richard H Maley; Rodney J Landreneau; Robert J Keenan
Journal:  Ann Thorac Surg       Date:  2006-02       Impact factor: 4.330

6.  Comparison Between Stereotactic Radiotherapy and Sublobar Resection for Non-Small Cell Lung Cancer.

Authors:  Masaya Tamura; Isao Matsumoto; Yusuke Tanaka; Daisuke Saito; Shuhei Yoshida; Seiichi Kakegawa; Tomoyasu Kumano; Yosuke Shimizu; Hiroyasu Tamamura; Tsuyoshi Takanaka; Hirofumi Takemura
Journal:  Ann Thorac Surg       Date:  2018-11-17       Impact factor: 4.330

7.  Lobectomy versus stereotactic body radiotherapy in healthy patients with stage I lung cancer.

Authors:  Joshua E Rosen; Michelle C Salazar; Zuoheng Wang; James B Yu; Roy H Decker; Anthony W Kim; Frank C Detterbeck; Daniel J Boffa
Journal:  J Thorac Cardiovasc Surg       Date:  2016-04-07       Impact factor: 5.209

8.  Survival following sublobar resection for early-stage non-small cell lung cancer with or without adjuvant external beam radiation therapy: a population-based study.

Authors:  Justin Rineer; David Schreiber; Evangelia Katsoulakis; Thomas Nabhani; Peter Han; Christopher Lange; Kwang Choi; Marvin Rotman
Journal:  Chest       Date:  2009-09-11       Impact factor: 9.410

9.  Short report: interim safety results for a phase II trial measuring the integration of stereotactic ablative radiotherapy (SABR) plus surgery for early stage non-small cell lung cancer (MISSILE-NSCLC).

Authors:  David A Palma; Timothy K Nguyen; Keith Kwan; Stewart Gaede; Mark Landis; Richard Malthaner; Dalilah Fortin; Alexander V Louie; Eric Frechette; George B Rodrigues; Brian Yaremko; Edward Yu; A Rashid Dar; Ting-Yim Lee; Al Gratton; Andrew Warner; Aaron Ward; Richard Inculet
Journal:  Radiat Oncol       Date:  2017-01-27       Impact factor: 3.481

10.  Survival following lobectomy vs limited resection for stage I lung cancer: a meta-analysis.

Authors:  H Nakamura; N Kawasaki; M Taguchi; K Kabasawa
Journal:  Br J Cancer       Date:  2005-03-28       Impact factor: 7.640
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.